BR112013012107A2 - vacina multivalente, vetor recombinante, vetor de expressão, célula hospedeira recombinante, e, método para imunizar um animal contra filaríase - Google Patents

vacina multivalente, vetor recombinante, vetor de expressão, célula hospedeira recombinante, e, método para imunizar um animal contra filaríase

Info

Publication number
BR112013012107A2
BR112013012107A2 BR112013012107A BR112013012107A BR112013012107A2 BR 112013012107 A2 BR112013012107 A2 BR 112013012107A2 BR 112013012107 A BR112013012107 A BR 112013012107A BR 112013012107 A BR112013012107 A BR 112013012107A BR 112013012107 A2 BR112013012107 A2 BR 112013012107A2
Authority
BR
Brazil
Prior art keywords
recombinant
vector
immunizing
host cell
multivalent vaccine
Prior art date
Application number
BR112013012107A
Other languages
English (en)
Other versions
BR112013012107B1 (pt
Inventor
Kalyanasundaram Ramaswamy
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of BR112013012107A2 publication Critical patent/BR112013012107A2/pt
Publication of BR112013012107B1 publication Critical patent/BR112013012107B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112013012107-6A 2010-11-15 2011-11-07 Proteína de fusão recombinante, molécula de ácido nucleico, vetor recombinante, microrganismo transgênico, e, vacina multivalente BR112013012107B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41368110P 2010-11-15 2010-11-15
US61/413,681 2010-11-15
US201161449954P 2011-03-07 2011-03-07
US61/449,954 2011-03-07
US201161522079P 2011-08-10 2011-08-10
US61/522,079 2011-08-10
PCT/US2011/059501 WO2012067866A2 (en) 2010-11-15 2011-11-07 Multivalent vaccine for filariasis

Publications (2)

Publication Number Publication Date
BR112013012107A2 true BR112013012107A2 (pt) 2017-10-10
BR112013012107B1 BR112013012107B1 (pt) 2021-06-01

Family

ID=46084573

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013012107-6A BR112013012107B1 (pt) 2010-11-15 2011-11-07 Proteína de fusão recombinante, molécula de ácido nucleico, vetor recombinante, microrganismo transgênico, e, vacina multivalente

Country Status (8)

Country Link
US (1) US20130236490A1 (pt)
EP (1) EP2640417B1 (pt)
CN (1) CN103298485B (pt)
BR (1) BR112013012107B1 (pt)
ES (1) ES2800984T3 (pt)
PT (1) PT2640417T (pt)
SG (1) SG190822A1 (pt)
WO (1) WO2012067866A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids
CN104368014B (zh) * 2014-10-21 2017-04-12 南通大学 周期型马来丝虫m29表位基因dna疫苗的制备方法
CN106399346B (zh) * 2014-11-05 2019-10-18 南通大学 周期型马来丝虫m29表位基因蛋白疫苗的用途
WO2017011380A1 (en) * 2015-07-14 2017-01-19 The Board Of Trustees Of The University Of Illinois Vaccine and methods for detecting and preventing filariasis
MA44624A (fr) 2016-04-07 2019-02-13 Merial Inc Vaccin contre le ver du c ur, procédés et utilisations associés
US20200276285A1 (en) 2017-06-02 2020-09-03 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
CN110051832B (zh) * 2019-05-31 2020-11-10 四川农业大学 一种犬恶丝虫病疫苗
CN110133291B (zh) * 2019-05-31 2020-11-13 四川农业大学 犬恶丝虫小热休克蛋白的应用
CN110133290B (zh) * 2019-05-31 2021-02-26 四川农业大学 一种诊断犬恶丝虫病的elisa试剂盒
EP4038222A4 (en) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University METHODS AND COMPOSITIONS FOR IDENTIFYING NEOANTIGENS FOR USE IN THE TREATMENT AND PREVENTION OF CANCER

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6172194A (en) 1993-02-08 1994-08-29 Paravax, Inc. Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens

Also Published As

Publication number Publication date
ES2800984T3 (es) 2021-01-07
WO2012067866A2 (en) 2012-05-24
CN103298485A (zh) 2013-09-11
CN103298485B (zh) 2016-10-12
EP2640417A4 (en) 2014-05-28
EP2640417A2 (en) 2013-09-25
PT2640417T (pt) 2020-06-25
WO2012067866A8 (en) 2013-07-18
SG190822A1 (en) 2013-07-31
BR112013012107B1 (pt) 2021-06-01
WO2012067866A3 (en) 2012-07-19
EP2640417B1 (en) 2020-04-01
US20130236490A1 (en) 2013-09-12

Similar Documents

Publication Publication Date Title
BR112013012107A2 (pt) vacina multivalente, vetor recombinante, vetor de expressão, célula hospedeira recombinante, e, método para imunizar um animal contra filaríase
BR112013030321A2 (pt) composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
BR112014002006A2 (pt) proteína de fusão, célula engenheirada para expressar a proteína de fusão, vetor, e, método para tratar um paciente com câncer
BR112013002765A2 (pt) implante deflectível, sistema e métodos para implantação do mesmo
BR112012024287A2 (pt) anticorpo, composição farmacêutica, método, ácido nucleico, vetor de expressão e célula hospedeira
BR112015003847A2 (pt) dispositivo flexível, e método para operar um dispositivo flexível
BRPI0912263A2 (pt) composição de vacina, e, método para imunizar uma cobaia animal contra coccidiose
BR112014011034A2 (pt) rede, e, método para operação de uma rede das virtual
BR112014015562A2 (pt) aerofólio e método para fabricar um aerofólio
BR112014007613A2 (pt) aparelho e método para controlar um implante
BR112013033350A2 (pt) imunocitocina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica
EP2694834A4 (en) HAERGLATTUNGSFORMULIERUNGEN KERATINBASIS AND PROCESS THEREFOR AND SYSTEMS WITH IT
BRPI1010950A2 (pt) método para preparação de emulsão carregada de fármaco.
BR112014015511A2 (pt) método para tingir as fibras queratínicas humanas e dispositivo
BR112013007955A2 (pt) composição de tensoativo, composição de limpeza de cuidado pessoal, e, método para espessar um tensoativo aquoso
BR112013004373A2 (pt) dispositivo de interface com o paciente, método de ajuste de um dispositivo de interface com o paciente e almofada para dispositivo de interface com o paciente
EP2708153A4 (en) METHOD AND DEVICE FOR HUMIDIFYING HAIR AND REDUCING CAPILLARY DEGRADATION
BR112015008819A2 (pt) tanque de armazenagem submarino, e método para instalar um tanque de armazenagem submarino
BR112013015942A2 (pt) dispositivos de bomba e métodos para utilizar os mesmos.
EP2689770A4 (en) DAMAGED HAIR CARE AND METHOD FOR IMPROVING THE CONDITION OF DAMAGED HAIR THEREWITH
BR112013030395A2 (pt) polipeptídeo, polinucleotídeo, vetor, composição imunogênica, vacina, e, uso de uma composição imunogênica
EP2796476A4 (en) EMULSIFYING AGENT FOR EMULSION POLYMERIZATION, AND EMULSION POLYMERIZATION METHOD USING THE SAME
BR112013031760A2 (pt) vacina contra coronavírus canino
BR112013030846A2 (pt) vetor de expressão, célula hospedeira não humana, método para a fabricação de uma proteína e uso de um vetor de expressão
DK2709656T3 (da) Proteinmatrix-vaccinesammensætninger omfattende polykationer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/11/2011, OBSERVADAS AS CONDICOES LEGAIS.